Canopy Growth Corp - CGC Net earnings per share for the last 12 months

Tweed (CGC) - corporate logo

Canopy Growth (CGC) possesses limited pricing power due to intense competition and elastic demand. The business is currently undergoing a complex asset optimization and the reduction of excess capacity, which is constraining profit growth. Historical price action relative to EPS (TTM) stands at 73.30, reflecting the performance of a company whose success relies on brand recognition and the expansion of legal sales markets.

CGC Canopy Growth Corp Earnings per share for the last twelve months (02/11/2024 - 11/13/2026)

CGC (Tweed): analytical breakdowns and indicator data

- market value and analyst target forecast:
Stock Quotes canopygrowth.com|CGC - Analyst Consensus Forecast
- issuer market value details:
Market Valuation Canopy Growth Corp|CGC - Enterprise Value
- book capitalization data:
Book Value per Share Canopy Growth|CGC - Company Book Value|Capitalization to Book Value Ratio canopygrowth.com|CGC - Aggregate Company Assets
- company total debt and liquidity indicators:
Debt to Capital Canopy Growth|CGC - Long-Term Debt to Equity|Current Liabilities to Equity Canopy Growth Corp.|CGC - Company Total Debt|Debts to Book Value Canopy Growth Corp|CGC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Canopy Growth|Critical Liquidity canopygrowth.com
- earnings and multiples data:
CGC - Company Net Income|Expected Net Income Canopy Growth|CGC - Price to Earnings Ratio|Projected Price to Earnings Ratio Canopy Growth Corp|CGC - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Canopy Growth Corp|CGC - Operating profit before deduction of amortization|Earnings per share for the last four quarters Canopy Growth|CGC - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months canopygrowth.com|CGC - Earnings growth in current year|Expected earnings per share growth for next year Canopy Growth
Fundamental valuation:CGC, canopygrowth.com
Core merchandise of Canopy Growth Corp

Oversupply pressure in Canada and legalization complexities in the US drive the current year-over-year EPS growth dynamics over a rolling period. This indicator reflects the actual rate of change in earnings per share, stripping away market illusions. The calculation is based on a comparison of the current aggregate income over 12 months against the same interval from the previous year. This metric characterizes Canopy Growth (CGC) as a high-risk asset with unstable fundamental value.

Direct competitors

indivior.com (INDV) - Net earnings per share for the last 12 months|COLL: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Cronos Group Inc|HITI (High Tide Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Aurora|Earnings per share for the last twelve months Achieve Life Sciences (ACHV)|Skye Bioscience Inc. - Earnings per share for the last 12 months|Earnings per share for the last twelve months Anebulo Pharmaceuticals, Inc. ANEB|InterCure Ltd (INCR) - Net earnings per one share for the last twelve months|NTRB - Earnings per share for the last twelve months|Earnings per one share for the last 12 months NSRX|IGC (igcinc.us) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months MIRA Pharmaceuticals, Inc. (MIRA)|Net earnings per share for the last 12 months FLGC|IMCC: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ADIL|artelobio.com (ARTL) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Ensysce Biosciences, Inc. ENSC|Earnings per share for the trailing year TTNP|GNLN - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months InMed Pharmaceuticals Inc|AKAN (Akanda Corporation) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Enveric Corp|Net earnings per share for the last 12 months BGXX|HPCO (hempaccoinc.com) - Earnings per share for the last four quarters